Breaking News
Get 40% Off 0
Join +750K new investors every month who copy stock picks from billionaire's portfolios Sign Up Free

Stock Markets Analysis & Opinion

Contribute
Edison
Achillion Pharmaceuticals: Pipeline Advancing   By Edison - May 08, 2017

Achillion Pharmaceuticals Inc (NASDAQ:ACHN) recently announced that its partner, Janssen, has fully enrolled its 365-patient Phase IIb trial testing the triple combination of ALS-022335, simeprevir...

Continue with Google
or
Sign up with Email